KEMEELYT GARCIA: Open Payments
NPI 1912636366 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 58 payments from 15 companies in 2025. Trend: 2023 $771 · 2024 $1,039 · 2025 $1,079
Food & beverage: $1,079
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $333 |
| Amgen Inc. | 17 | $173 |
| GlaxoSmithKline, LLC. | 9 | $151 |
| Exact Sciences Corporation | 4 | $104 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| ABBVIE INC. | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Lilly USA, LLC | 1 | $26 |
| Philips North America LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $21 |
Products named: Ozempic, TRELEGY ELLIPTA, Cologuard Collection Kit, EVENITY, GEMTESA, OTEZLA, Rybelsus, JARDIANCE.
Industry payments across FL — which companies pay providers there.
